dc.contributor | History of Twentieth Century Medicine Group | |
dc.contributor | History of Modern Biomedicine Research Group | |
dc.date.accessioned | 2017-05-18T08:54:53Z | |
dc.date.available | 2017-05-18T08:54:53Z | |
dc.date.issued | 18/05/2017 | |
dc.date.submitted | 2017-05-17T10:43:14.213Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23154 | |
dc.description.abstract | Selection of photos taken at the Witness Seminar “Monoclonal Antibodies” held by the History of Twentieth Century Medicine Group, 24-Sep-1993. Participants: Dr Ita Askonas, Dr Basil Bard, Sir Christopher Booth (Chair), Dr Robert Bud, Dr John Galloway, Sir James Gowans, Sir John Gray, Dr Georges Köhler, Dr César Milstein, Mr John Newell, Dr David Owen, Dr David Secher, Dr David Tyrrell, Dr Guil Winchester, Professor Miles Weatherall, and Dr Peter Williams. | en_US |
dc.description.sponsorship | The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity (no. 210183). The creation and curation of the current photo collection has been funded by the Wellcome Trust Strategic Award entitled “Makers of modern biomedicine: testimonies and legacy” (2012-2017; awarded to Professor Tilli Tansey). | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | History of Modern Biomedicine Witness Seminars (Photo Collection);eWS01a.01 | |
dc.relation.ispartofseries | History of Modern Biomedicine Witness Seminars (Photo Collection);eWS01a.02 | |
dc.relation.ispartofseries | History of Modern Biomedicine Witness Seminars (Photo Collection);eWS01a.03 | |
dc.relation.isbasedon | http://qmro.qmul.ac.uk/jspui/handle/123456789/2745 | |
dc.rights | Attribution 3.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | |
dc.subject | History of Modern Biomedicine Research Group | en_US |
dc.subject | History of Twentieth Century Medicine Group | en_US |
dc.subject | Images | en_US |
dc.subject | Witness Seminars | en_US |
dc.subject | monoclonal antibodies | en_US |
dc.subject | biotechnology | en_US |
dc.subject | hybridoma | en_US |
dc.subject | pure culture | en_US |
dc.subject | antibody specificity | en_US |
dc.subject | genetic engineering | en_US |
dc.subject | immunology | en_US |
dc.subject | myeloma | en_US |
dc.subject | National Research Development Corporation (NRDC) | en_US |
dc.subject | antigen | en_US |
dc.title | WS01a: Technology Transfer in Britain: The Case of Monoclonal Antibodies (24-Sep-1993) | en_US |
dc.type | Image | en_US |